Inhibition of potassium transport and growth of mycobacteria exposed to clofazimine and B669 is associated with a calcium-independent increase in microbial phospholipase A2 activity
Open Access
- 1 August 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 44 (2) , 209-216
- https://doi.org/10.1093/jac/44.2.209
Abstract
Altered phospholipase A2 (PLA2) activity and its relationship to cation (K+, Ca2+) uptake and growth were investigated in mycobacteria exposed to the riminophenazine antimicrobial agents, clofazimine and B669 (0.15–2.5 mg/L). Microbial PLA2 activity was measured using a radiometric thin-layer chromatography procedure, whereas K+ and Ca2+ transport were measured using 86Rb+ or 42K+ and 45Ca2+, respectively. Short-term exposure (15–30 min) of Mycobacterium aurum A+ or the virulent and avirulent isolates of Mycobacterium tuberculosis H37R to the riminophenazines resulted in dose-related enhancement of microbial PLA2 activity, which was associated with inhibition of K+ influx and growth. Uptake of Ca2+ by mycobacteria was unaffected, or minimally affected, by the riminophenazines at concentrations of ≤0.6 mg/L, whereas higher concentrations resulted in increased uptake of the cation in the setting of decreased microbial ATP concentrations. The results of kinetic studies using a fixed concentration (2.5 mg/L) of B669 demonstrated that riminophenazine-mediated enhancement of PLA2 activity and inhibition of K+ uptake in mycobacteria are rapid and probably related events that precede, by several minutes, any detectable effects on microbial ATP concentrations and uptake of Ca2+. Inclusion of the extracellular and intracellular Ca2+-chelating agents EGTA (0.2–7.2 g/L) and BAPTA/FURA-2 (0.2–9.5 mg/L), individually or in combination, did not prevent the effects of B669 on mycobacterial PLA2 activity or K+ transport, whereas α-tocopherol, which neutralizes PLA2 primary hydrolysis products, antagonized the inhibitory effects of the riminophenazines on microbial K+ uptake and growth. These results demonstrate that the antimycobacterial activities of clofazimine and B669 are related to a Ca2+-independent increase in mycobacterial PLA2, leading to interference with microbial K+ transport.Keywords
This publication has 17 references indexed in Scilit:
- Evidence for a calmodulin-dependent phospholipase A2 that inhibits Na-K-ATPase.American Journal of Physiology-Cell Physiology, 1997
- The riminophenazines, clofazimine and B669, inhibit potassium transport in Gram-positive bacteria by a lysophospholipid-dependent mechanismJournal of Antimicrobial Chemotherapy, 1996
- Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipidsAntimicrobial Agents and Chemotherapy, 1992
- Tocopherol Stabilizes Membrane against Phospholipase A, Free Fatty Acids, and LysophospholipidsaAnnals of the New York Academy of Sciences, 1989
- [1] Overview: The Na,K-pumpPublished by Elsevier ,1988
- Potassium transport in Escherichia coli: diverse systems with common control by osmotic forcesTrends in Biochemical Sciences, 1980
- Discrimination between Rb+ and K+ by Escherichia coliBiochimica et Biophysica Acta (BBA) - Biomembranes, 1977
- Cation transport in Escherichia coli. VIII. Potassium transport mutants.The Journal of general physiology, 1976
- Increased membrane atpase and K+ transport rates in streptococcusfaecalis induced by K+ restriction during growthBiochemical and Biophysical Research Communications, 1971
- A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis ActivityNature, 1957